TrialThe lancet. HIV2016

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial.

BREATHER (PENTA 16) Trial GroupPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.